| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2014-10-06 | Point72 Asset Management, L.P. | CymaBay Therapeutics, Inc. | 229,883 | 1.6% | EDGAR |
| SC 13G | 2014-04-08 | Flynn James E | CymaBay Therapeutics, Inc. | 593,206 | 5.8% | EDGAR |
| SC 13G | 2014-02-14 | ALTA BIOPHARMA PARTNERS III LP | CymaBay Therapeutics, Inc. | 1,029,126 | 10.8% | EDGAR |
| SC 13G | 2014-02-13 | Versant Affiliates Fund II-A, LP | CymaBay Therapeutics, Inc. | 9,768 | 0.1% | EDGAR |